| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1855 | 2021 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 344 | 2021 |
| Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a US–Canadian multicenter study N Bräu, RK Fox, P Xiao, K Marks, Z Naqvi, LE Taylor, A Trikha, ... Journal of hepatology 47 (4), 527-537, 2007 | 320 | 2007 |
| Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America MA Thompson, MA Horberg, AL Agwu, JA Colasanti, MK Jain, WR Short, ... Clinical infectious diseases 73 (11), e3572-e3605, 2021 | 206 | 2021 |
| Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial LR Metsch, DJ Feaster, L Gooden, T Matheson, M Stitzer, M Das, MK Jain, ... Jama 316 (2), 156-170, 2016 | 203 | 2016 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The Lancet Respiratory Medicine 9 (12), 1365-1376, 2021 | 150 | 2021 |
| Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated … C Orrell, DP Hagins, E Belonosova, N Porteiro, S Walmsley, V Falcó, ... The Lancet HIV 4 (12), e536-e546, 2017 | 142 | 2017 |
| Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999–2000 MK Jain, DJ Skiest, JW Cloud, CL Jain, D Burns, RE Berggren Clinical infectious diseases 36 (8), 1030-1038, 2003 | 134 | 2003 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 129 | 2022 |
| Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ... The Lancet Respiratory Medicine 7 (11), 951-963, 2019 | 129 | 2019 |
| Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial JH Beigel, E Aga, MC Elie-Turenne, J Cho, P Tebas, CL Clark, JP Metcalf, ... The Lancet Respiratory Medicine 7 (11), 941-950, 2019 | 109 | 2019 |
| Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection ÁH Borges, J Neuhaus, AG Babiker, K Henry, MK Jain, A Palfreeman, ... Clinical Infectious Diseases 63 (12), 1668-1676, 2016 | 109 | 2016 |
| Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients With Suspected or Known COVID-19 (November 2021) JB Lynch, P Davitkov, DJ Anderson, A Bhimraj, VCC Cheng, ... Clinical Infectious Diseases 78 (7), e230-e249, 2024 | 107 | 2024 |
| RNA editing of Filamin A pre‐mRNA regulates vascular contraction and diastolic blood pressure M Jain, TD Mann, M Stulić, SP Rao, A Kirsch, D Pullirsch, X Strobl, C Rath, ... The EMBO journal 37 (19), e94813, 2018 | 106 | 2018 |
| Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis H Price, D Dunn, D Pillay, F Bani-Sadr, T de Vries-Sluijs, MK Jain, ... PloS one 8 (7), e68152, 2013 | 106 | 2013 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 96 | 2022 |
| The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in … RJ Bedimo, H Drechsler, M Jain, J Cutrell, S Zhang, X Li, I Farukhi, ... PloS one 9 (8), e106221, 2014 | 90 | 2014 |
| Gamma/delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections DA Kosub, G Lehrman, JM Milush, D Zhou, E Chacko, A Leone, S Gordon, ... Journal of virology 82 (3), 1155-1165, 2008 | 79 | 2008 |
| Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment RJ Wong, MK Jain, G Therapondos, ML Shiffman, O Kshirsagar, C Clark, ... Official journal of the American College of Gastroenterology| ACG 113 (9 …, 2018 | 78 | 2018 |
| Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response MK Jain, L Comanor, C White, P Kipnis, C Elkin, K Leung, A Ocampo, ... Journal of viral hepatitis 14 (3), 176-182, 2007 | 76 | 2007 |
